Publications by authors named "Carlton D Dampier"

Claim this Profile
A
Arginine Therapy for Pain in Sickle Cell Disease: A Phase-2 Randomized, Placebo-Controlled Trial.
Claudia R Morris, Dunia Hatabah, Rawan Korman, Scott Gillespie, Nitya Bakshi, Carlton D Dampier

Am J Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
Carlton D Dampier, Marilyn Jo Telen, Ted Wun, R Clark Brown, Payal Desai

Blood· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain.
Claudia R Morris, Lou Ann S Brown, Michael Reynolds, Carlton D Dampier, Peter A Lane

Blood· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iCanCope with Sickle Cell Pain: Design of a randomized controlled trial of a smartphone and web-based pain self-management program for youth with sickle cell disease.
Tonya M Palermo, William T Zempsky, Carlton D Dampier, Chitra Lalloo, Amos S Hundert

Contemp Clin Trials· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial).
Ahmed A Daak, Carlton D Dampier, Beng Fuh, Julie Kanter, Ofelia A Alvarez

Blood Adv· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial designs and models for analgesic medications for acute pain in neonates, infants, toddlers, children, and adolescents: ACTTION recommendations.
Gary A Walco, Ernest A Kopecky, Steven J Weisman, Jennifer Stinson, Bonnie Stevens, Carlton D Dampier

Pain· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROMIS(®) pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions.
Darren A DeWalt, Heather E Gross, Debbie S Gipson, David T Selewski, Esi Morgan DeWitt, Carlton D Dampier

Qual Life Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
Scott T Miller, Hae-Young Kim, Debra L Weiner, Carrie G Wager, Dianne Gallagher, Carlton D Dampier

Transfusion· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.
Carlton D Dampier, Wally R Smith, Carrie G Wager, Hae-Young Kim, Margaret C Bell

Clin Trials· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of PCA strategies on pain intensity and functional assessment measures in adults with sickle cell disease during hospitalized vaso-occlusive episodes.
Carlton D Dampier, Carrie G Wager, Ryan Harrison, Lewis L Hsu, Caterina P Minniti

Am J Hematol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis.
B N Yamaja Setty, Nigel S Key, A Koneti Rao, Suhita Gayen-Betal, Suba Krishnan, Carlton D Dampier

Br J Haematol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trial.
Marlene H Peters-Lawrence, Margaret C Bell, Lewis L Hsu, Ifeyinwa Osunkwo, Phillip Seaman, Carlton D Dampier

Contemp Clin Trials· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inpatient management of sickle cell pain: a 'snapshot' of current practice.
Scott T Miller, Hae-Young Kim, Debra Weiner, Carrie G Wager, Dianne Gallagher, Carlton D Dampier

Am J Hematol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric analgesic clinical trial designs, measures, and extrapolation: report of an FDA scientific workshop.
Charles B Berde, Gary A Walco, Elliot J Krane, K J S Anand, Jacob V Aranda, Carlton D Dampier

Pediatrics· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes.
Carlton D Dampier, Wally R Smith, Hae-Young Kim, Carrie Greene Wager, Margaret C Bell

Am J Hematol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing abstract numerical and visual depictions of risk in survey of parental assessment of risk in sickle cell hydroxyurea treatment.
Chavis A Patterson, Lamia P Barakat, Phyllis K Henderson, Faith Nall, Anna Westin, Carlton D Dampier

J Pediatr Hematol Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitions of the phenotypic manifestations of sickle cell disease.
Samir K Ballas, Susan Lieff, Lennette J Benjamin, Carlton D Dampier, Matthew M Heeney

Am J Hematol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis